India could approve Russia’s Sputnik V vaccine against COVID-19 within the next few weeks, the RIA news agency cited India’s ambassador to Moscow as saying on Monday.
Small human trials of the Russian vaccine have been ongoing in India, conducted by India’s Dr. Reddy’s Laboratories Ltd (REDY.NS) and supported by the Russian Direct Investment Fund (RDIF).
February 15, 2021
Our Standards: The Thomson Reuters Trust Principles.
Categories: India News